Related Experiment Video
Updated: Sep 20, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis
Anne-Cécile Brisset1, Anne-Dominique Terrisse, Dominique Dupouy
1Laboratoire d'Hématologie, Pavillon Caubet, Hôpital Purpan, 31059 Toulouse Cedex, France.
Abstract:
As apoptosis of neo-intimal SMCs is a feature of advanced atherosclerotic plaques, the procoagulant properties of SMCs of synthetic phenotype undergoing apoptosis were investigated. SMCs isolated from rat aorta obtained 10 days after balloon injury, previously found to up-regulate Tissue Factor (TF) and Tissue Factor Inhibitor (TFPI) and to release large amounts of TFPI (Ghrib et al. Thromb Haemost 2002;87:1043-50), were sensitive to the apoptosis induced by Fas-ligand. During this process, surface TF activity rose by a factor 10 over 6 hours, in parallel with a proportional increase in prothrombinase, while TF protein expressed at the membrane significantly decreased. The microparticles (MPs) produced during SMC death bore intact and functional TF, but the release of TFPI did not change, so that the balance shifted to a procoagulant state during apoptosis. Shed MPs enhanced thrombus formation in flowing whole blood over collagen coated-glass slides. Apoptotic SMCs in atherosclerotic plaques represent a reservoir of highly thrombogenic material, released into the blood stream in case of spontaneous or mechanical plaque disruption.
Insights
Apoptosis of synthetic smooth muscle cells (SMCs) in atherosclerotic plaques increases their procoagulant potential. Shed microparticles from dying SMCs promote thrombus formation, highlighting thrombotic risks in advanced atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Thrombosis Research
- Atherosclerosis Pathogenesis
Background:
- Apoptosis of neo-intimal smooth muscle cells (SMCs) is characteristic of advanced atherosclerotic plaques.
- SMCs in synthetic phenotype up-regulate Tissue Factor (TF) and Tissue Factor Inhibitor (TFPI), releasing significant TFPI.
Purpose of the Study:
- To investigate the procoagulant properties of synthetic SMCs during apoptosis.
- To determine the role of SMC-derived microparticles in thrombosis.
Main Methods:
- Isolation of SMCs from rat aorta post-balloon injury.
- Induction of apoptosis using Fas-ligand.
- Measurement of surface TF activity, prothrombinase, and TFPI release.
- Analysis of microparticle (MP) procoagulant function in vitro and in whole blood flow models.
Main Results:
- Fas-ligand induced apoptosis in SMCs.
- Surface TF activity increased 10-fold, with a proportional rise in prothrombinase, while membrane TF protein decreased.
- Microparticles shed during SMC death carried functional TF, with unchanged TFPI release, shifting the balance towards a procoagulant state.
- Shed MPs enhanced thrombus formation in flowing whole blood.
Conclusions:
- Apoptotic SMCs in atherosclerotic plaques are a source of highly thrombogenic material.
- Release of TF-bearing MPs during SMC death contributes to plaque thrombogenicity.
- Plaque disruption can release this procoagulant material into circulation, increasing thrombotic risk.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
The Intrinsic Apoptotic Pathway
Apoptosis
Clot Retraction and Fibrinolysis

